M&A Deal Summary

Cordis Acquires MedAlliance

On October 18, 2022, Cordis acquired medical products company MedAlliance from Trustar Capital for 1.1B USD

Acquisition Highlights
  • This is Cordis’ 3rd transaction in the Medical Products sector.
  • This is Cordis’ largest (disclosed) transaction.
  • This is Cordis’ 1st transaction in Switzerland.

M&A Deal Summary
Date 2022-10-18
Target MedAlliance
Sector Medical Products
Buyer(s) Cordis
Sellers(s) Trustar Capital
Deal Type Add-on Acquisition
Deal Value 1.1B USD

Target

MedAlliance

Nyon, Switzerland
MedAlliance is a privately-owned medical technology company that specializes in development of technology and commercialization of advanced drug-device combination products for the treatment of coronary and peripheral artery diseases. MedAlliance founded in 2008 and is based in Nyon, Switzerland.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cordis

Miami Lakes, Florida, United States
Category Company
Founded 1966
Sector Medical Products
Revenue 780M USD (2014)
DESCRIPTION

Cordis is a provider of cardiovascular and endovascular medical devices. Founded in 1966, the Company has a long history of innovation in high-quality and minimally-invasive cardiovascular technology. Its products are primarily used in procedures to diagnose and treat the narrowing or blockage of arteries. Cordis was founded in 1966 and is based in Miami Lakes, Florida.

DEAL STATS #
Overall 4 of 4
Sector (Medical Products) 3 of 3
Type (Add-on Acquisition) 4 of 4
Country (Switzerland) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-12 Flexible Stenting Solutions

Eatontown, New Jersey, United States

Flexible Stenting Solutions, Inc. is a developer of innovative flexible peripheral arterial, venous and biliary stents.

Buy -

Seller(S) 1

SELLER

Trustar Capital

Hong Kong, China

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1978
PE ASSETS 7.7B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Trustar Capital is the private equity arm of financial services/asset manager CITIC Group. Trustar Capital separates its private equity investment activity into three groups; China, Japan, and the US. In general, Trustar looks to invest in companies with 'strong franchises', with established brands and high barriers to entry. For US-based opportunities, the firm looks to leverage its connections in China. Broad areas of interest include niche manufacturing, consumer products, and business services. The Firm does not invest in start-ups or distressed businesses. Trustar Capital is based in Hong Kong.

DEAL STATS #
Overall 22 of 24
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 11 of 12
Country (Switzerland) 1 of 1
Year (2022) 2 of 3
Size (of disclosed) 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-21 Salion Foods

Beijing, China

Salion Foods specializes in R&D, manufacturing, and distribution of compound condiments and basic food ingredients. Salion Foods offers nearly a thousand SKUs covering hundreds of basic food ingredients, Chinese and western flavor sauce, hotpot soup base, hotpot dipping sauce, powder seasonings and etc. Salion Foods was founded in 2000 and is based in Beijing, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-01 LifeStyles

Singapore, Singapore

LifeStyles is specialized in sexual wellness sector, possessing a broad product range. LifeStyles was founded in 1905 and is based in Singapore.

Sell -
Mergr

Product

Company

Legal